Pacific Edge Limited Share Price and Company Fundamentals



Price
$0.45
Change
0.005 (1.124%)
52 week
0.4 - 1.39

Last traded: Last Friday at 3:59 AM

Pacific Edge Limited, a cancer diagnostic company, researches, develops, and commercializes diagnostic and prognostic tools for the early detection and management of cancers in New Zealand, the United States, Australia, and Singapore. It operates in two segments, Commercial and Research. The company offers Cxbladder, a genomic urine tests for the detection and management of bladder cancer. It is also developing Cxbladder Resolve, a product that identifies those patients who are likely to have aggressive or more advanced bladder cancer; Cxbladder Triage, a product that identifies patients with haematuria who have a low probability of bladder cancer; Cxbladder Detect that enables the non-invasive detection of bladder and other urinary tract cancers; and Cxbladder Monitor, which allows urologists to monitor bladder cancer patients for recurrence of the disease. In addition, the company is developing Cxcolorectal, a prognostic gene signature for patients diagnosed with stage II or stage III colorectal cancers; and products for bladder, gastric, colorectal, endometrial cancers, and melanoma. Pacific Edge Limited was incorporated in 2001 and is headquartered in Dunedin, New Zealand.

Key Metrics

PE ratio

-

PB ratio

3.77

Dividend yield

0.00%

Beta

0.95

Market cap

-

Enterprise value

-

Company profile

Industry / Sector Diagnostics & Research / Healthcare
Full time employees 100
Website https://www.pacificedgedx.com
Mailing address Centre for Innovation 87 St David Street PO Box 56 Dunedin 9016 New Zealand
Phone / Fax 64 3 479 5800 / 64 3 479 5801

Dividends

Dividend yield

0.00%

Dividend amount

$0.00

Payout ratio

0.00%

Pacific Edge Limited paid $0.00 dividend and the ex-dividend date was .The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.PEB dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.

PEB's forward dividend amount is $ and the forward dividend yield is . A forward dividend yield is the percentage of a company's current stock price that it expects to pay out as dividends over a certain time period, generally 12 months. Forward dividend yields are generally used in circumstances where the yield is predictable based on past instances. If not, trailing yields, which indicate the same value over the previous 12 months, are used.

Company Executives

As of Dec 2022, following are the company executives and directors listed on Pacific Edge Limited.

Name Title Age Total Pay
Dr. Peter Meintjes Chief Exec. Officer
Mr. Grant Gibson Chief Financial Officer
Mr. Darrell Morgan Chief Operating Officer
Dr. Justin Harvey Chief Technology Officer
Prof. Parry Guilford Ph.D. Chief Scientific Officer & Member of Scientific Advisory Board
Mr. Jack Atchason Sr. VP of Sales - Pacific Edge Diagnostics USA Limited
Mr. Andrew McIntosh Chief Digital Officer
Mr. David Levison Exec. Chairman & Pres of Pacific Edge Diagnostics USA 61 53k

Profitability and management effectiveness

Profit margin

-129.70%

Operating margin

-155.57%

Return on assets

-15.50%

Return on equity

-22.24%

Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.

The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.

Valuation and Trading Info

The market capitalization of Pacific Edge Limited is and its enterprise value is .

The PEB's stocks Beta value is 0.95 making it 5% less volatile compared to NZX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.

Pacific Edge Limited (NZX:PEB) Frequently Asked Questions

1. What is Pacific Edge Limited's Stock Symbol?

Pacific Edge Limited trades on NZX under the ticker symbol "PEB".

2. What is Pacific Edge Limited's stock price today?

One share of PEB stock can currently be purchased for approximately $0.45.

3. How can I contact Pacific Edge Limited?

Pacific Edge Limited's mailing address is Centre for Innovation 87 St David Street PO Box 56 Dunedin 9016 New Zealand. The company can be reached via phone at 64 3 479 5800.

4. What is Pacific Edge Limited's official website?

The official website of Pacific Edge Limited is https://www.pacificedgedx.com.